Attention-Deficit/Hyperactivity Disorder Center

Gold Divider 4Col

Clinical Trials

Research Services Offered (include evaluation and treatment options):

This study is sponsored by the National Institute of Mental Health.

Measuring and Predicting Response to Methylphenidate and Atomexetine
For children and adolescents 7-17 years with attention problems and who may have ADHD.  Study participation includes evaluation and medication treatment.

For further information, please call Robyn Palmero at (877) 234-3411.

(800) MD-SINAI (800) 637-4624

Visit Mount Sinai Queens